Syncona（SYNC）株式概要シンコナ・リミテッドは、複数の資産クラスにわたるヘッジファンド、株式ファンド、長期オルタナティブ投資ファンドへの投資を専門とするファンドである。 詳細SYNC ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金0/6SYNC Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUK£Current PriceUK£0.98該当なし内在価値ディスカウントEst. Revenue$PastFuture-215m404m2016201920222025202620282031Revenue UK£0.2Earnings UK£0.07AdvancedSet Fair ValueView all narrativesSyncona Limited 競合他社 価格と性能株価の高値、安値、推移の概要Syncona過去の株価現在の株価UK£0.9852週高値UK£1.0352週安値UK£0.80ベータ0.311ヶ月の変化11.49%3ヶ月変化-1.01%1年変化13.95%3年間の変化-36.36%5年間の変化-53.77%IPOからの変化-5.31%最新ニュースお知らせ • Aug 08Syncona Limited Announces Board ChangesSyncona Limited announced, following its Annual General Meeting (AGM), Virginia Holmes has retired from the Board. Kemal Malik will take up the role of Senior Independent Director, effective immediately. He joined the Syncona Board in 2020, bringing 30 years of experience in global pharmaceutical research and development. In line with the Company's strategy update on 19 June 2025, in the event a new investment objective and policy, is approved by shareholders, the Company would expect to reduce the size of the Board for the new strategy.お知らせ • Jul 02Syncona Limited, Annual General Meeting, Aug 05, 2025Syncona Limited, Annual General Meeting, Aug 05, 2025.お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025お知らせ • Nov 19Syncona Limited Announces Step Down of Gian Piero Reverberi as Member of Its Board Audit CommitteeSyncona Limited announced the following board committee change: Following a review of board committee composition, Gian Piero Reverberi will step down as a member of the company's board audit committee with immediate effect.お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025お知らせ • Sep 20Syncona Limited Announces Appointment of John Roche as an Independent Non-Executive Director, Effective from 1 October 2024Syncona Limited announced the appointment of John Roche as an independent Non-Executive Director, with effect from 1 October 2024. John brings many years of broad financial experience to the role, having spent more than 15 years as a Partner at PricewaterhouseCoopers in Guernsey. During this time he served as managing partner of the Guernsey office for seven years and was leader of the Capital Markets Practice for twelve years. While at PwC, John specialised in providing audit and capital markets advisory services to listed investment companies and alternative asset management clients, developing extensive valuation experience. John is a Fellow of the Institute of Chartered Accountants in Ireland, who retired from practice in 2022. He is a Non-Executive Director and Chair of the Audit Committee of Riverstone Energy Limited, and a Guernsey resident. On appointment, John will join the Company's Audit Committee.最新情報をもっと見るRecent updatesお知らせ • Aug 08Syncona Limited Announces Board ChangesSyncona Limited announced, following its Annual General Meeting (AGM), Virginia Holmes has retired from the Board. Kemal Malik will take up the role of Senior Independent Director, effective immediately. He joined the Syncona Board in 2020, bringing 30 years of experience in global pharmaceutical research and development. In line with the Company's strategy update on 19 June 2025, in the event a new investment objective and policy, is approved by shareholders, the Company would expect to reduce the size of the Board for the new strategy.お知らせ • Jul 02Syncona Limited, Annual General Meeting, Aug 05, 2025Syncona Limited, Annual General Meeting, Aug 05, 2025.お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025お知らせ • Nov 19Syncona Limited Announces Step Down of Gian Piero Reverberi as Member of Its Board Audit CommitteeSyncona Limited announced the following board committee change: Following a review of board committee composition, Gian Piero Reverberi will step down as a member of the company's board audit committee with immediate effect.お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025お知らせ • Sep 20Syncona Limited Announces Appointment of John Roche as an Independent Non-Executive Director, Effective from 1 October 2024Syncona Limited announced the appointment of John Roche as an independent Non-Executive Director, with effect from 1 October 2024. John brings many years of broad financial experience to the role, having spent more than 15 years as a Partner at PricewaterhouseCoopers in Guernsey. During this time he served as managing partner of the Guernsey office for seven years and was leader of the Capital Markets Practice for twelve years. While at PwC, John specialised in providing audit and capital markets advisory services to listed investment companies and alternative asset management clients, developing extensive valuation experience. John is a Fellow of the Institute of Chartered Accountants in Ireland, who retired from practice in 2022. He is a Non-Executive Director and Chair of the Audit Committee of Riverstone Energy Limited, and a Guernsey resident. On appointment, John will join the Company's Audit Committee.お知らせ • Jul 05Syncona Limited, Annual General Meeting, Aug 06, 2024Syncona Limited, Annual General Meeting, Aug 06, 2024. Location: the offices of citco fund services, guernsey limited, frances house, sir william place, United Kingdomお知らせ • Jun 26Syncona Limited to Report Q1, 2025 Results on Aug 15, 2024Syncona Limited announced that they will report Q1, 2025 results on Aug 15, 2024お知らせ • Jun 21Syncona Limited to Report First Half, 2025 Results on Nov 14, 2024Syncona Limited announced that they will report first half, 2025 results on Nov 14, 2024お知らせ • Jan 05Syncona Limited to Report Q3, 2024 Results on Feb 08, 2024Syncona Limited announced that they will report Q3, 2024 results on Feb 08, 2024お知らせ • Nov 15Syncona Limited to Report Fiscal Year 2024 Results on Jun 20, 2024Syncona Limited announced that they will report fiscal year 2024 results on Jun 20, 2024お知らせ • Oct 19Syncona Seeks to Buy Remaining Shares of Freeline TherapeuticsSyncona Limited (LSE:SYNC) that its investment manager has submitted a proposal to buy the shares of Freeline Therapeutics Holdings plc (NasdaqCM:FRLN) that it doesn't already own, and plans to start talks with the company over a potential deal. The U.K. healthcare company said Wednesday that it is offering to pay $5.00 for each American Depositary Share of Freeline, a 20% premium over the volume weighted average price of $4.16 between Oct. 4 and Oct. 16. Syncona, which currently owns approximately 57.9% of Freeline, said there isn't a guarantee that any deal will be agreed. Syncona shares at 10:30 GMT were up 0.20 pence, or 0.2%, at 126.20 pence.お知らせ • Jun 29Syncona Limited to Report First Half, 2024 Results on Nov 16, 2023Syncona Limited announced that they will report first half, 2024 results on Nov 16, 2023お知らせ • Jun 28Syncona Limited, Annual General Meeting, Aug 01, 2023Syncona Limited, Annual General Meeting, Aug 01, 2023, at 09:30 Coordinated Universal Time. Location: Citco Fund Services (Guernsey) Limited, Frances House, Sir William Place, St Peter Port, Guernsey GY1 1GX Guernsey United Kingdom Agenda: To consider The Directors must lay the annual audited accounts for the financial year ended 31 March 2023 and the reports of the Directors and Auditors before the Shareholders and the Shareholders will be asked to receive and consider the financial statements and the reports; to consider Shareholders will be asked to confirm the reappointment of Deloitte LLP (Guernsey Branch) as Auditors until the conclusion of the next annual general meeting due to be held in 2024 and to grant authority to the Board to determine their remuneration; and to transact such other business matter.お知らせ • Dec 07Syncona Limited to Report Q3, 2023 Results on Feb 07, 2023Syncona Limited announced that they will report Q3, 2023 results on Feb 07, 2023株主還元SYNCGB Capital MarketsGB 市場7D5.0%3.4%2.5%1Y14.0%-7.2%19.4%株主還元を見る業界別リターン: SYNC過去 1 年間で-7.2 % の収益を上げたUK Capital Markets業界を上回りました。リターン対市場: SYNCは、過去 1 年間で19.4 % のリターンを上げたUK市場を下回りました。価格変動Is SYNC's price volatile compared to industry and market?SYNC volatilitySYNC Average Weekly Movement2.8%Capital Markets Industry Average Movement4.5%Market Average Movement5.7%10% most volatile stocks in GB Market11.9%10% least volatile stocks in GB Market3.1%安定した株価: SYNC 、 UK市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: SYNCの 週次ボラティリティ ( 3% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20121,215Chris Hollowoodwww.synconaltd.comシンコナ・リミテッドは、複数の資産クラスにわたるヘッジ、エクイティ、長期オルタナティブ投資ファンドへの投資を専門とするファンドである。プライベート・エクイティ、債券、債券、オルタナティブ投資を運用している。当ファンドは、細胞治療、遺伝子治療、生物製剤、低分子を中心としたヘルスケア・ライフサイエンス分野への投資を好んでいる。当ファンドは世界中の公開株式および債券市場に投資する。複数の資産クラスを対象に、実績のある運用会社の主要なロング・オンリー・ファンドやオルタナティブ投資ファンドに投資することで、魅力的な中長期リターンを目指す。個別管理勘定ポートフォリオに投資する。もっと見るSyncona Limited 基礎のまとめSyncona の収益と売上を時価総額と比較するとどうか。SYNC 基礎統計学時価総額UK£596.03m収益（TTM）-UK£93.58m売上高(TTM)n/a-8.9xP/Sレシオ-6.4xPER（株価収益率SYNC は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計SYNC 損益計算書（TTM）収益-UK£67.18m売上原価UK£0売上総利益-UK£67.18mその他の費用UK£26.40m収益-UK£93.58m直近の収益報告Sep 30, 2025次回決算日該当なし一株当たり利益（EPS）-0.15グロス・マージン100.00%純利益率139.30%有利子負債／自己資本比率0%SYNC の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 13:48終値2026/05/22 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Syncona Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Kane SlutzkinDeutsche BankPaul CuddonDeutsche BankKenneth RumphJefferies LLC1 その他のアナリストを表示
お知らせ • Aug 08Syncona Limited Announces Board ChangesSyncona Limited announced, following its Annual General Meeting (AGM), Virginia Holmes has retired from the Board. Kemal Malik will take up the role of Senior Independent Director, effective immediately. He joined the Syncona Board in 2020, bringing 30 years of experience in global pharmaceutical research and development. In line with the Company's strategy update on 19 June 2025, in the event a new investment objective and policy, is approved by shareholders, the Company would expect to reduce the size of the Board for the new strategy.
お知らせ • Jul 02Syncona Limited, Annual General Meeting, Aug 05, 2025Syncona Limited, Annual General Meeting, Aug 05, 2025.
お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025
お知らせ • Nov 19Syncona Limited Announces Step Down of Gian Piero Reverberi as Member of Its Board Audit CommitteeSyncona Limited announced the following board committee change: Following a review of board committee composition, Gian Piero Reverberi will step down as a member of the company's board audit committee with immediate effect.
お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025
お知らせ • Sep 20Syncona Limited Announces Appointment of John Roche as an Independent Non-Executive Director, Effective from 1 October 2024Syncona Limited announced the appointment of John Roche as an independent Non-Executive Director, with effect from 1 October 2024. John brings many years of broad financial experience to the role, having spent more than 15 years as a Partner at PricewaterhouseCoopers in Guernsey. During this time he served as managing partner of the Guernsey office for seven years and was leader of the Capital Markets Practice for twelve years. While at PwC, John specialised in providing audit and capital markets advisory services to listed investment companies and alternative asset management clients, developing extensive valuation experience. John is a Fellow of the Institute of Chartered Accountants in Ireland, who retired from practice in 2022. He is a Non-Executive Director and Chair of the Audit Committee of Riverstone Energy Limited, and a Guernsey resident. On appointment, John will join the Company's Audit Committee.
お知らせ • Aug 08Syncona Limited Announces Board ChangesSyncona Limited announced, following its Annual General Meeting (AGM), Virginia Holmes has retired from the Board. Kemal Malik will take up the role of Senior Independent Director, effective immediately. He joined the Syncona Board in 2020, bringing 30 years of experience in global pharmaceutical research and development. In line with the Company's strategy update on 19 June 2025, in the event a new investment objective and policy, is approved by shareholders, the Company would expect to reduce the size of the Board for the new strategy.
お知らせ • Jul 02Syncona Limited, Annual General Meeting, Aug 05, 2025Syncona Limited, Annual General Meeting, Aug 05, 2025.
お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025
お知らせ • Nov 19Syncona Limited Announces Step Down of Gian Piero Reverberi as Member of Its Board Audit CommitteeSyncona Limited announced the following board committee change: Following a review of board committee composition, Gian Piero Reverberi will step down as a member of the company's board audit committee with immediate effect.
お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025
お知らせ • Sep 20Syncona Limited Announces Appointment of John Roche as an Independent Non-Executive Director, Effective from 1 October 2024Syncona Limited announced the appointment of John Roche as an independent Non-Executive Director, with effect from 1 October 2024. John brings many years of broad financial experience to the role, having spent more than 15 years as a Partner at PricewaterhouseCoopers in Guernsey. During this time he served as managing partner of the Guernsey office for seven years and was leader of the Capital Markets Practice for twelve years. While at PwC, John specialised in providing audit and capital markets advisory services to listed investment companies and alternative asset management clients, developing extensive valuation experience. John is a Fellow of the Institute of Chartered Accountants in Ireland, who retired from practice in 2022. He is a Non-Executive Director and Chair of the Audit Committee of Riverstone Energy Limited, and a Guernsey resident. On appointment, John will join the Company's Audit Committee.
お知らせ • Jul 05Syncona Limited, Annual General Meeting, Aug 06, 2024Syncona Limited, Annual General Meeting, Aug 06, 2024. Location: the offices of citco fund services, guernsey limited, frances house, sir william place, United Kingdom
お知らせ • Jun 26Syncona Limited to Report Q1, 2025 Results on Aug 15, 2024Syncona Limited announced that they will report Q1, 2025 results on Aug 15, 2024
お知らせ • Jun 21Syncona Limited to Report First Half, 2025 Results on Nov 14, 2024Syncona Limited announced that they will report first half, 2025 results on Nov 14, 2024
お知らせ • Jan 05Syncona Limited to Report Q3, 2024 Results on Feb 08, 2024Syncona Limited announced that they will report Q3, 2024 results on Feb 08, 2024
お知らせ • Nov 15Syncona Limited to Report Fiscal Year 2024 Results on Jun 20, 2024Syncona Limited announced that they will report fiscal year 2024 results on Jun 20, 2024
お知らせ • Oct 19Syncona Seeks to Buy Remaining Shares of Freeline TherapeuticsSyncona Limited (LSE:SYNC) that its investment manager has submitted a proposal to buy the shares of Freeline Therapeutics Holdings plc (NasdaqCM:FRLN) that it doesn't already own, and plans to start talks with the company over a potential deal. The U.K. healthcare company said Wednesday that it is offering to pay $5.00 for each American Depositary Share of Freeline, a 20% premium over the volume weighted average price of $4.16 between Oct. 4 and Oct. 16. Syncona, which currently owns approximately 57.9% of Freeline, said there isn't a guarantee that any deal will be agreed. Syncona shares at 10:30 GMT were up 0.20 pence, or 0.2%, at 126.20 pence.
お知らせ • Jun 29Syncona Limited to Report First Half, 2024 Results on Nov 16, 2023Syncona Limited announced that they will report first half, 2024 results on Nov 16, 2023
お知らせ • Jun 28Syncona Limited, Annual General Meeting, Aug 01, 2023Syncona Limited, Annual General Meeting, Aug 01, 2023, at 09:30 Coordinated Universal Time. Location: Citco Fund Services (Guernsey) Limited, Frances House, Sir William Place, St Peter Port, Guernsey GY1 1GX Guernsey United Kingdom Agenda: To consider The Directors must lay the annual audited accounts for the financial year ended 31 March 2023 and the reports of the Directors and Auditors before the Shareholders and the Shareholders will be asked to receive and consider the financial statements and the reports; to consider Shareholders will be asked to confirm the reappointment of Deloitte LLP (Guernsey Branch) as Auditors until the conclusion of the next annual general meeting due to be held in 2024 and to grant authority to the Board to determine their remuneration; and to transact such other business matter.
お知らせ • Dec 07Syncona Limited to Report Q3, 2023 Results on Feb 07, 2023Syncona Limited announced that they will report Q3, 2023 results on Feb 07, 2023
